Preeclampsia: Pathophysiology, Challenges, and Perspectives
- PMID: 30920918
- DOI: 10.1161/CIRCRESAHA.118.313276
Preeclampsia: Pathophysiology, Challenges, and Perspectives
Erratum in
-
Correction to: Preeclampsia: Pathophysiology, Challenges, and Perspectives.Circ Res. 2020 Jan 3;126(1):e8. doi: 10.1161/RES.0000000000000315. Epub 2020 Jan 2. Circ Res. 2020. PMID: 31895662 No abstract available.
Abstract
Hypertensive disorders of pregnancy-chronic hypertension, gestational hypertension, and preeclampsia-are uniquely challenging as the pathology and its therapeutic management simultaneously affect mother and fetus, sometimes putting their well-being at odds with each other. Preeclampsia, in particular, is one of the most feared complications of pregnancy. Often presenting as new-onset hypertension and proteinuria during the third trimester, preeclampsia can progress rapidly to serious complications, including death of both mother and fetus. While the cause of preeclampsia is still debated, clinical and pathological studies suggest that the placenta is central to the pathogenesis of this syndrome. In this review, we will discuss the current evidence for the role of abnormal placentation and the role of placental factors such as the antiangiogenic factor, sFLT1 (soluble fms-like tyrosine kinase 1) in the pathogenesis of the maternal syndrome of preeclampsia. We will discuss angiogenic biomarker assays for disease-risk stratification and for the development of therapeutic strategies targeting the angiogenic pathway. Finally, we will review the substantial long-term cardiovascular and metabolic risks to mothers and children associated with gestational hypertensive disorders, in particular, preterm preeclampsia, and the need for an increased focus on interventional studies during the asymptomatic phase to delay the onset of cardiovascular disease in women.
Keywords: biomarkers; blood pressure; cardiovascular disease; preeclampsia; pregnancy.
Similar articles
-
Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.Obstet Gynecol Clin North Am. 2010 Jun;37(2):239-53. doi: 10.1016/j.ogc.2010.02.013. Obstet Gynecol Clin North Am. 2010. PMID: 20685551 Review.
-
Preeclampsia: the role of angiogenic factors in its pathogenesis.Physiology (Bethesda). 2009 Jun;24:147-58. doi: 10.1152/physiol.00043.2008. Physiology (Bethesda). 2009. PMID: 19509125 Review.
-
Molecular mechanisms of preeclampsia.Microvasc Res. 2008 Jan;75(1):1-8. doi: 10.1016/j.mvr.2007.04.009. Epub 2007 May 6. Microvasc Res. 2008. PMID: 17553534 Free PMC article. Review.
-
Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Epub 2010 Jul 19. Circulation. 2010. PMID: 20644016
-
Evidence-Based Revised View of the Pathophysiology of Preeclampsia.Adv Exp Med Biol. 2017;956:355-374. doi: 10.1007/5584_2016_168. Adv Exp Med Biol. 2017. PMID: 27873232 Review.
Cited by
-
Biomarkers for Early Prediction and Management of Preeclampsia: A Comprehensive Review.Med Sci Monit. 2024 May 23;30:e944104. doi: 10.12659/MSM.944104. Med Sci Monit. 2024. PMID: 38781124 Free PMC article. Review.
-
Data-driven insights can transform women's reproductive health.NPJ Womens Health. 2024;2(1):14. doi: 10.1038/s44294-024-00019-x. Epub 2024 May 14. NPJ Womens Health. 2024. PMID: 38770215 Free PMC article. Review.
-
The sFlt-1/PlGF Ratio at 12, 24, and 32 Weeks Gestation in Twin Pregnancies as a Predictor of Late Preterm Birth and Perinatal Event Secondary to Prematurity.J Clin Med. 2024 May 4;13(9):2699. doi: 10.3390/jcm13092699. J Clin Med. 2024. PMID: 38731228 Free PMC article.
-
Understanding the Pathophysiology of Preeclampsia: Exploring the Role of Antiphospholipid Antibodies and Future Directions.J Clin Med. 2024 May 2;13(9):2668. doi: 10.3390/jcm13092668. J Clin Med. 2024. PMID: 38731197 Free PMC article. Review.
-
Preeclamptic heart failure - perioperative concerns and management: a narrative review.Perioper Med (Lond). 2024 May 10;13(1):37. doi: 10.1186/s13741-024-00391-x. Perioper Med (Lond). 2024. PMID: 38730290 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous